Michael Richman Archives · BioBuzz

NextCure’s Inaugural International Day Celebrates Life Sciences Diversity, Mission-driven Spirit

Life Sciences Diversity

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="Life Sciences Diversity" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-300x300.png?lossy=1&strip=1&webp=1 300w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-640x640.png?lossy=1&strip=1&webp=1 640w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-675x675.png?lossy=1&strip=1&webp=1 675w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day-768x768.png?lossy=1&strip=1&webp=1 768w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/11/Next-Cure-International-Day.png?lossy=1&strip=1&webp=1 1080w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : November 29, 2022December 2, 2022 Published by : Steven Surdez

On International Day, the entire company had a chance to put down their laptops and lab coats for a bit to celebrate their remarkable diversity.

NextCure Launches New GLP Lab, Expands In-House Capabilities

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/nextcure-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/nextcure-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/nextcure-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/nextcure.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/10/nextcure-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 18, 2022October 18, 2022 Published by : Steven Surdez

For NextCure, a fast-growing, publicly-traded (Nasdaq: NXTC) clinical-stage biotech located in Beltsville, Maryland, choosing to invest in and build capabilities in-house aligned with its mission to serve patients that do not respond to existing therapies.

NextCure Featured on Business Spotlight Video Series

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/06/nextcure-pg-county-business-spotlight-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/06/nextcure-pg-county-business-spotlight-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/06/nextcure-pg-county-business-spotlight-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/06/nextcure-pg-county-business-spotlight.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2022/06/nextcure-pg-county-business-spotlight-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : June 13, 2022June 13, 2022 Published by : Steven Surdez

NextCure, an emerging global leader in developing novel immunomedicines to treat cancer and other immune-related diseases, was recently featured on Prince George’s County Economic Development Corporation’s (PGCEDC) Business Spotlight video series.

NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/04/NextCure-logo-75x75.jpg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/04/NextCure-logo-100x100.jpg?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/04/NextCure-logo-150x150.jpg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/04/NextCure-logo.jpg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : April 29, 2019April 30, 2019 Published by : Chris Frew

NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline April 29, 2019 NextCure, a clinical-stage biotech in Beltsville, MD developing cancer immunotherapies, announced the terms for its IPO that [….]